{"id":"W4410339360","doi":"10.1371/journal.pmed.1004472","title":"Safety and tolerability of intravenous liposomal GM1 in patients with Parkinson disease: A single-center open-label clinical phase I trial (NEON trial)","year":2025,"lang":"en","type":"article","venue":"PLoS Medicine","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Medicine; Tolerability; Adverse effect; Pharmacokinetics; Single Center; Internal medicine; Placebo; Clinical trial; Randomized controlled trial; Pathology","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001965623,0.001641603,0.002425591,0.0002848668,0.0003860816,0.0007831954,0.0008130857,0.001819732,0.002840115],"category_scores_gemma":[0.00119696,0.0004752337,0.001065202,0.0002208907,0.001288015,0.001230198,0.0005426257,0.002453602,0.0007934289],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007668406,"about_ca_system_score_gemma":0.00114305,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002475879,"about_ca_topic_score_gemma":0.0005268684,"domain_scores_codex":[0.9994531,0.0002909008,0.00002576387,0.00012276,0.00003523949,0.00007218712],"domain_scores_gemma":[0.9992187,0.0001386352,0.0001903837,0.00007063364,0.00005434932,0.0003273351],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9071736,0.02524311,0.002226286,0.0005096849,0.0004283204,0.0001691618,0.0002153248,0.0008724393,0.0204427,0.0001640449,0.001217818,0.04133744],"study_design_scores_gemma":[0.671116,0.3227203,0.002955795,0.00002622187,0.0001198523,0.0001562938,0.0000312376,0.0006853482,0.001449992,0.0001356405,0.0005838607,0.00001940245],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9955689,0.001177126,0.0005031576,0.0002657304,0.00006463595,0.001469566,0.0003546676,0.00006545371,0.0005307247],"genre_scores_gemma":[0.9926381,0.0006892179,0.001631849,0.0004737314,0.000116861,0.002893969,0.0006339129,0.00002129008,0.0009010201],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002840115,"threshold_uncertainty_score":0.01039535,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05658254167827469,"score_gpt":0.3497033761656043,"score_spread":0.2931208344873296,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}